ATE412766T1 - Verfahren zur herstellung von herzmuskelzellen und verfahren zur suche von behandlungen von herzerkrankungen - Google Patents

Verfahren zur herstellung von herzmuskelzellen und verfahren zur suche von behandlungen von herzerkrankungen

Info

Publication number
ATE412766T1
ATE412766T1 AT01945643T AT01945643T ATE412766T1 AT E412766 T1 ATE412766 T1 AT E412766T1 AT 01945643 T AT01945643 T AT 01945643T AT 01945643 T AT01945643 T AT 01945643T AT E412766 T1 ATE412766 T1 AT E412766T1
Authority
AT
Austria
Prior art keywords
heart muscle
heart
muscle cells
cells
apoptosis
Prior art date
Application number
AT01945643T
Other languages
English (en)
Inventor
Haruhide Kimura
Nobuyuki Koyama
Seiichi Tanida
Tadamitsu Kishimoto
Keiko Takihara
Hisao Hirota
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE412766T1 publication Critical patent/ATE412766T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01945643T 2000-06-28 2001-06-27 Verfahren zur herstellung von herzmuskelzellen und verfahren zur suche von behandlungen von herzerkrankungen ATE412766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000194805 2000-06-28

Publications (1)

Publication Number Publication Date
ATE412766T1 true ATE412766T1 (de) 2008-11-15

Family

ID=18693571

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945643T ATE412766T1 (de) 2000-06-28 2001-06-27 Verfahren zur herstellung von herzmuskelzellen und verfahren zur suche von behandlungen von herzerkrankungen

Country Status (6)

Country Link
US (2) US20030175847A1 (de)
EP (2) EP2090663A3 (de)
AT (1) ATE412766T1 (de)
AU (1) AU2001267844A1 (de)
DE (1) DE60136358D1 (de)
WO (1) WO2002000850A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262095A1 (en) * 2002-09-17 2004-04-08 Ken-Ichiro Hata Cell dispersing apparatus, cell dispersion cassette and tissue retention part
US8168718B2 (en) 2005-12-09 2012-05-01 Exxonmobil Chemical Patents Inc. Thermoplastic vulcanizate adhesive compositions
EP2226633A1 (de) * 2009-03-06 2010-09-08 Charité - Universitätsmedizin Berlin Verwendungen und Verfahren zur Identifikation einer zytoprotektiven Verbindung mit gp130 oder LIFRalpha
CN108949673A (zh) * 2018-08-13 2018-12-07 武汉华联科生物技术有限公司 一种大鼠胎鼠心肌细胞原代分离方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948725A (en) * 1974-05-30 1976-04-06 Godo Shusei Kabushiki Kaisha Neutral protease useful for animal tissue and cell culture
JPH0372872A (ja) * 1988-07-12 1991-03-28 Bio Kagaku Kenkyusho:Kk 無血清培地及びそれを用いた哺乳類細胞の培養法
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
US5378698A (en) * 1991-10-21 1995-01-03 Shionogi & Co., Ltd. Benzothiazepine derivatives
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US6133233A (en) * 1997-02-18 2000-10-17 Kansas State University Research Foundation Peptide modulation of reperfusion injury
US6043066A (en) * 1997-09-04 2000-03-28 Mangano; Joseph A. Cell separation using electric fields
EP1023441A1 (de) * 1997-10-16 2000-08-02 The Board Of Regents, The University Of Texas System Modellen und behandlungen zur herz-hypertrophie in verbindung mit nf-at3 funktion

Also Published As

Publication number Publication date
WO2002000850A1 (fr) 2002-01-03
EP1295936A4 (de) 2004-11-10
EP2090663A2 (de) 2009-08-19
EP1295936B1 (de) 2008-10-29
DE60136358D1 (de) 2008-12-11
EP1295936A1 (de) 2003-03-26
US20030175847A1 (en) 2003-09-18
EP2090663A3 (de) 2009-11-11
AU2001267844A1 (en) 2002-01-08
US20080160553A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
Summer et al. Origin and phenotype of lung side population cells
Navasiolava et al. Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers
Raynaud et al. Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation
Tournadre et al. Immature muscle precursors are a source of interferon‐β in myositis: role of Toll‐like receptor 3 activation and contribution to HLA class I up‐regulation
CN105331580B (zh) 增强间充质干细胞趋化能力和趋化因子ccl5表达方法
Tyagi et al. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart‐derived fibroblast and endomyocardial endothelial cells
Liao et al. Isolation, culture, and functional analysis of adult mouse cardiomyocytes
Luebke-Wheeler et al. E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism
Fu et al. Beneficial effect of human umbilical cord‑derived mesenchymal stem cells on an endotoxin‑induced rat model of preeclampsia
Fu et al. Conditioned medium from human amnion‐derived mesenchymal stem cells regulates activation of primary hepatic stellate cells
Gorodkiewicz et al. Cathepsin D serum and urine concentration in superficial and invasive transitional bladder cancer as determined by surface plasmon resonance imaging
CN105238738A (zh) 一种仔猪心肌成纤维细胞的分离培养方法
Dolbeare et al. A fluorescent assay of proteinases in cultured mammalian cells.
ATE412766T1 (de) Verfahren zur herstellung von herzmuskelzellen und verfahren zur suche von behandlungen von herzerkrankungen
JPWO2019235362A1 (ja) 線維化抑制組成物、これを生産する細胞、およびこの細胞からなる細胞シート
CN103239479B (zh) 一种人原发性皮肤鳞状上皮细胞癌肿瘤干细胞的动物模型建立方法
CN103389376A (zh) 评估肝细胞癌临床分期和预后的试剂盒及ecscr 的应用
Gillespie et al. Quantitative electron microscopy of the interalveolar septa of the horse lung
Praet et al. Histological characterization and quantification of cellular events following neural and fibroblast (-like) stem cell grafting in healthy and demyelinated CNS tissue
Choi et al. Relationships between cytokine levels and disease parameters during the development of a collagen-induced arthritis model in cynomolgus macaques (Macaca fascicularis)
CN103305460B (zh) 一种人表皮干细胞的分离和培养方法
Couderc et al. Poliovirus permissivity and specific receptor expression on human endothelial cells
CN105920025B (zh) 托吡酯在治疗心肌梗死的药品中应用
Sel et al. The in vitro Treatment of Mesenchymal Stem Cells for Colorectal Cancer Cells
Steinbach et al. Skin-derived precursors from human subjects with Type 2 diabetes yield dysfunctional vascular smooth muscle cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties